Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tongue Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 4pembrolizumab 2Radiotherapy 2Paclitaxel 2tozuleristide 1niraparib 1dostarlimab 1dacomitinib 1advexin 1Taxes 1Sirolimus 1Photochemotherapy 1Pemetrexed 1Gemcitabine 1Fluorodeoxyglucose F18 1FPP(RGD)2 1Chemoprevention 1Celecoxib 1Calcitriol 1Aminolevulinic Acid 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Mouth Neoplasms × advexin × Clear all
NCT00064103 2013-01-23

Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx

National Cancer Institute (NCI)

Phase 1/2 Completed
51 enrolled
Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡